{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:26:42Z","timestamp":1768562802546,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["IWT.140193"],"award-info":[{"award-number":["IWT.140193"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-025-01359-8","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:54:15Z","timestamp":1767956055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interreader agreement of intraprostatic prostate cancer detection, local extension and staging using [18F]PSMA-1007 PET and whole-mount radical prostatectomy specimens"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-0161","authenticated-orcid":false,"given":"Niloefar","family":"Ahmadi Bidakhvidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7026-6535","authenticated-orcid":false,"given":"Elena","family":"Lara Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9080-2370","authenticated-orcid":false,"given":"Hannes","family":"Leupe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3602-9078","authenticated-orcid":false,"given":"Sander","family":"Jentjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-2944","authenticated-orcid":false,"given":"Marcella","family":"Baldewijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9829-8535","authenticated-orcid":false,"given":"Maxim","family":"De Schepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1371-442X","authenticated-orcid":false,"given":"Annouschka","family":"Laenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-915X","authenticated-orcid":false,"given":"Ga\u00ebtan","family":"Devos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3345-4573","authenticated-orcid":false,"given":"Alexander","family":"Giesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-640X","authenticated-orcid":false,"given":"Michel","family":"Koole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-1577","authenticated-orcid":false,"given":"Christophe M.","family":"Deroose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3157-7115","authenticated-orcid":false,"given":"Wouter","family":"Everaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3195-9890","authenticated-orcid":false,"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7453-0229","authenticated-orcid":false,"given":"Karolien","family":"Goffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"1359_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10:63\u201389. https:\/\/doi.org\/10.14740\/wjon1191.","journal-title":"World J Oncol"},{"key":"1359_CR2","volume-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer","author":"P Cornford","year":"2025","unstructured":"Cornford P, Tilki D, van den Bergh RCN, Eberli D, De Meerleer G, De Santis M, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Arnhem, The Netherlands: European Association of Urology; 2025."},{"key":"1359_CR3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.eururo.2018.11.031","volume":"75","author":"DC Johnson","year":"2019","unstructured":"Johnson DC, Raman SS, Mirak SA, Kwan L, Bajgiran AM, Hsu W, et al. Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging. Eur Urol. 2019;75:712\u201320. https:\/\/doi.org\/10.1016\/j.eururo.2018.11.031.","journal-title":"Eur Urol"},{"key":"1359_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.juro.2016.07.084","volume":"197","author":"A Priester","year":"2017","unstructured":"Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, et al. Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. J Urol. 2017;197:320\u20136. https:\/\/doi.org\/10.1016\/j.juro.2016.07.084.","journal-title":"J Urol"},{"key":"1359_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.urology.2019.04.023","volume":"130","author":"C Draulans","year":"2019","unstructured":"Draulans C, Everaerts W, Isebaert S, Gevaert T, Oyen R, Joniau S, et al. Impact of magnetic resonance imaging on prostate cancer staging and European association of urology risk classification. Urology. 2019;130:113\u20139. https:\/\/doi.org\/10.1016\/j.urology.2019.04.023.","journal-title":"Urology"},{"key":"1359_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0167-4781(98)00200-0","volume":"1443","author":"DS O'Keefe","year":"1998","unstructured":"O\u2019Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, et al. Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim Biophys Acta. 1998;1443:113\u201327. https:\/\/doi.org\/10.1016\/s0167-4781(98)00200-0.","journal-title":"Biochim Biophys Acta"},{"key":"1359_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40336-023-00582-4","volume":"12","author":"P Claes","year":"2024","unstructured":"Claes P, Ahmadi Bidakhvidi N, Giesen A, Joniau S, Van Laere K, Koole M, et al. PSMA PET\/CT and PET\/MRI in primary staging of prostate cancer and its effect on patient management. Clin Translational Imaging. 2024;12:31\u201354. https:\/\/doi.org\/10.1007\/s40336-023-00582-4.","journal-title":"Clin Translational Imaging"},{"key":"1359_CR8","volume-title":"EAU-ESTRO-ESUR-SIOG guidelines on prostate cancer","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Briers E, Bolla M, Bourke L, Cornford P, et al. EAU-ESTRO-ESUR-SIOG guidelines on prostate cancer. Arnhem, The Netherlands: European Association of Urology; 2017."},{"key":"1359_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ph10040077","author":"J Cardinale","year":"2017","unstructured":"Cardinale J, Martin R, Remde Y, Sch\u00e4fer M, Hienzsch A, H\u00fcbner S, et al. Procedures for the GMP-compliant production and quality control of [18F]PSMA-1007: a next generation radiofluorinated tracer for the detection of prostate cancer. Pharmaceuticals (Basel). 2017. https:\/\/doi.org\/10.3390\/ph10040077.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1359_CR10","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00259-024-06903-7","volume":"52","author":"N Ahmadi Bidakhvidi","year":"2025","unstructured":"Ahmadi Bidakhvidi N, Gevaert T, De Schepper M, Baldewijns M, Havinga E, Deckers W, et al. Comparison of PSMA immunohistochemistry scoring systems to parametric. Eur J Nucl Med Mol Imaging. 2025;52:766\u201378. https:\/\/doi.org\/10.1007\/s00259-024-06903-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1359_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41824-025-00250-y","volume":"9","author":"H Leupe","year":"2025","unstructured":"Leupe H, Ahmadi Bidakhvidi N, Goffin K, Van den Broeck B, Jentjens S, Laenen A, et al. Comparison of inter- and intraobserver agreement between [18F]AlF-NOTA-octreotide and [68Ga]Ga-DOTA-SSA PET\/CT. EJNMMI Rep. 2025;9:17. https:\/\/doi.org\/10.1186\/s41824-025-00250-y.","journal-title":"EJNMMI Rep"},{"key":"1359_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","volume":"83","author":"R Seifert","year":"2023","unstructured":"Seifert R, Emmett L, Rowe SP, Herrmann K, Hadaschik B, Calais J, et al. <article-title update=\"added\">Second version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE\u00a0V2). Eur Urol. 2023;83:405\u201312. https:\/\/doi.org\/10.1016\/j.eururo.2023.02.002.","journal-title":"Eur Urol"},{"key":"1359_CR13","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.2967\/jnumed.121.263448","volume":"63","author":"L Emmett","year":"2022","unstructured":"Emmett L, Papa N, Buteau J, Ho B, Liu V, Roberts M, et al. The PRIMARY score: using Intraprostatic 68Ga-PSMA PET\/CT patterns to optimize prostate cancer diagnosis. J Nucl Med. 2022;63:1644\u201350. https:\/\/doi.org\/10.2967\/jnumed.121.263448.","journal-title":"J Nucl Med"},{"key":"1359_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2967\/jnumed.121.262398","volume":"63","author":"I Sonni","year":"2022","unstructured":"Sonni I, Felker ER, Lenis AT, Sisk AE, Bahri S, Allen-Auerbach M, et al. Head-to-Head Comparison of 68Ga-PSMA-11 PET\/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial. J Nucl Med. 2022;63:847\u201354. https:\/\/doi.org\/10.2967\/jnumed.121.262398.","journal-title":"J Nucl Med"},{"key":"1359_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"1359_CR16","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/jamaoncol.2024.3196","volume":"10","author":"N Mookerji","year":"2024","unstructured":"Mookerji N, Pfanner T, Hui A, Huang G, Albers P, Mittal R, et al. Fluorine-18 prostate-Specific membrane Antigen-1007 PET\/CT vs multiparametric MRI for locoregional staging of prostate cancer. JAMA Oncol. 2024;10:1097\u2013103. https:\/\/doi.org\/10.1001\/jamaoncol.2024.3196.","journal-title":"JAMA Oncol"},{"key":"1359_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.euo.2023.04.006","volume":"6","author":"L Exterkate","year":"2023","unstructured":"Exterkate L, Hermsen R, K\u00fcsters-Vandevelde HVN, Prette JF, Baas DJH, Somford DM, et al. Head-to-Head Comparison of 18F-PSMA-1007 Positron Emission Tomography\/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Whole-mount Histopathology as Reference in Localisation and Staging of Primary Prostate Cancer. Eur Urol Oncol. 2023;6:574\u201381. https:\/\/doi.org\/10.1016\/j.euo.2023.04.006.","journal-title":"Eur Urol Oncol"},{"key":"1359_CR18","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00259-024-06594-0","volume":"51","author":"ML Donswijk","year":"2024","unstructured":"Donswijk ML, Ettema RH, Meijer D, Wondergem M, Cheung Z, Bekers EM, et al. The accuracy and intra- and interobserver variability of PSMA PET\/CT for the local staging of primary prostate cancer. Eur J Nucl Med Mol Imaging. 2024;51:1741\u201352. https:\/\/doi.org\/10.1007\/s00259-024-06594-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1359_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41824-024-00234-4","volume":"9","author":"E Hvittfeldt","year":"2025","unstructured":"Hvittfeldt E, Hedeer F, Thimansson E, Sandeman K, Minarik D, Ingvar J, et al. Semi-standardized evaluation of extraprostatic extension and seminal vesicle invasion with [18F]PSMA-1007 PET\/CT: a comparison to MRI using histopathology as reference. EJNMMI Rep. 2025;9:1. https:\/\/doi.org\/10.1186\/s41824-024-00234-4.","journal-title":"EJNMMI Rep"},{"key":"1359_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/1754-9485.13084","volume":"64","author":"D Brauchli","year":"2020","unstructured":"Brauchli D, Singh D, Chabert C, Somasundaram A, Collie L. Tumour-capsule interface measured on 18F-DCFPyL PSMA positron emission tomography\/CT imaging comparable to multi-parametric MRI in predicting extra-prostatic extension of prostate cancer at initial staging. J Med Imaging Radiat Oncol. 2020;64:829\u201338. https:\/\/doi.org\/10.1111\/1754-9485.13084.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"1359_CR21","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1007\/s00259-022-05787-9","volume":"49","author":"R Laudicella","year":"2022","unstructured":"Laudicella R, R\u00fcschoff JH, Ferraro DA, Brada MD, Hausmann D, Mebert I, et al. Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on MpMRI. Eur J Nucl Med Mol Imaging. 2022;49:3917\u201328. https:\/\/doi.org\/10.1007\/s00259-022-05787-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1359_CR22","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023;50:1466\u201386. https:\/\/doi.org\/10.1007\/s00259-022-06089-w.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01359-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:27:45Z","timestamp":1768505265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-025-01359-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01359-8","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee Research UZ\/KU Leuven (EC Research; study number S59428) and complied with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Christophe M. Deroose is an employee of UZ Leuven. He is\/has been a consultant for (fees received by institution): Sirtex, Advanced Accelerator Applications, Novartis, Ipsen, Terumo, PSI CRO, Immedica Pharma, Molecular Partners, Nuclear Research and consultancy. His institution has received travel fees from: GE Healthcare, Sirtex. The other authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}